United States

Ionis Pharmaceuticals develops RNA-targeted therapeutics, including SPINRAZA for spinal muscular atrophy, TEGSEDI for hereditary transthyretin-mediated amyloidosis, and WAYLIVRA for familial chylomicronemia syndrome and familial partial lipodystrophy. The company also has medicines in development for various indications, including metabolic diseases, infectious diseases, renal diseases, ophthalmic diseases, and cancer. Ionis has collaborations with Biogen, AstraZeneca, Bayer, GlaxoSmithKline, Novartis, Roche, Janssen Biotech, and Flamingo Therapeutics.

Ionis Pharmaceuticals

Assistant Director, CMC / Development Chemistry

Principal Medical Writer - Regulatory and Medical Writing

Paralegal

Executive Director, Head of Strategic Sourcing

Cardiometabolic Account Specialist (CAS) - Western Brooklyn, NY

Cardiometabolic Account Specialist (CAS) - Northern Brooklyn, NY

Cardiometabolic Account Specialist (CAS) - Springfield, MO

Cardiometabolic Account Specialists (CAS) - Brooklyn, NY

Cardiometabolic Account Specialist (CAS) - North Miami, FL

Associate Director, Field Incentive Compensation

Google

Produktový manažér

Dátový vedec

Ionis Pharmaceuticals

Ionis Pharmaceuticals Otvorené pozície

Ste pripravení posunúť svoju kariéru na ďalšiu úroveň? Pozrite si tieto otvorené pozície v Ionis Pharmaceuticals.